相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
Christopher A. Todd et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2011)
Isolation of a Monoclonal Antibody That Targets the Alpha-2 Helix of gp120 and Represents the Initial Autologous Neutralizing-Antibody Response in an HIV-1 Subtype C-Infected Individual
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination
M. Anthony Moody et al.
PLOS ONE (2011)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Toward an Antibody-Based HIV-1 Vaccine
James A. Hoxie
ANNUAL REVIEW OF MEDICINE (2010)
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine
Peter Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Michael S. Seaman et al.
JOURNAL OF VIROLOGY (2010)
Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC
Tara G. Edmonds et al.
VIROLOGY (2010)
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men
Hui Li et al.
PLOS PATHOGENS (2010)
Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure
Tommi A. White et al.
PLOS PATHOGENS (2010)
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
Hua-Xin Liao et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
Samuel K. Lai et al.
JOURNAL OF VIROLOGY (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Simultaneous Evaluation of the Magnitude and Breadth of a Left- and Right-Censored Multivariate Response, With Application to HIV Vaccine Development
Yunda Huang et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2009)
Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
Penny L. Moore et al.
PLOS PATHOGENS (2009)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Jens Wrammert et al.
NATURE (2008)
Lessons from a multisite International trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120
Farley Cleghorn et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120 - Negative results fail to trigger a phase 3 correlates trial
Nina D. Russell et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization
Xinzhen Yang et al.
JOURNAL OF VIROLOGY (2006)
Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration
Vidita Choudhry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
PL Moore et al.
JOURNAL OF VIROLOGY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Intraepithelial cell neutralization of HIV-1 replication by IgA
YT Huang et al.
JOURNAL OF IMMUNOLOGY (2005)
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
S Nitayaphan et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
AIDS - Diversity considerations in HIV-1 vaccine selection
B Gaschen et al.
SCIENCE (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells
DN Forthal et al.
JOURNAL OF VIROLOGY (2001)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
分享论文
